Morpheus Genomics remains vigilant in advocating for patient safety and the implementation of pharmacogenomics
Scan
Scan
Scan
Scan
Scan
Share your information with your physician instantly
Our Mission
Revolutionizing medicine as we know it. Bringing it out of the current Dark Age of trial-and-error practice and transforming patient care into a Precision Medicine-based model Resulting in decreased morbidity, mortality, cost and increased patient safety, outcomes and satisfaction
Precision Medicine
Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.
DNA Testing
A sample is obtained from a simple cheek swab and sent to the laboratory. The individual's genetic makeup is determined, and specific drug metabolism can be evaluated.
Dr Jeff S Reid DO
Board Certified Anesthesiologist
Molecular Genetic Research Scientist
CPIC Anesthesia Guidelines
Pharmacogenomics Consulting
The Future is Here
Hospitals, private physician practices, pharmacies, and patients will soon realize they will each require specialized expertise to navigate the impending and never-ending surge of information that will accompany the transition of our current Dark Age practice of medicine to a Precision Medicine DNA-based model. The benefits in regard to decreased morbidity, mortality, and cost and increased patient safety and satisfaction will be enormous, as will be the amount of data and information that must be processed, analyzed, and acted upon to bring such benefits.
Morpheus Genomics stands to advance the field of pharmacogenomics and make this technology available and affordable for every human. Our goal is to lower the cost of DNA pharmacogenomic testing and to seamlessly break down the current barrier between the patient and the physician using actionable data, resulting in better outcomes for their patients.
Literature
Clin Pharmacol Ther 2011 Mar;89(3):464-7. doi: 10.1038/clpt.2010.279. Epub 2011 Jan 26.
CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network M V Relling 1, T E Klein
PMID: 21270786 PMCID: PMC3098762 DOI: 10.1038/clpt.2010.279
CPIC Guidelines
Clin Pharmacol Ther 2016 Aug;100(2):160-9. doi: 10.1002/cpt.350. Epub 2016 Jun 1.
Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network
W S Bush 1, D R Crosslin 2, A Owusu-Obeng 3, J Wallace 4, B Almoguera 5, M A Basford 6, S J Bielinski 7, D S Carrell 8, J J Connolly 5, D Crawford 1, K F Doheny 9, C J Gallego 2, A S Gordon 2, B Keating 5, J Kirby 6, T Kitchner 10, S Manzi 11, A R Mejia 3, V Pan 12, C L Perry 11, J F Peterson 6, C A Prows 13, J Ralston 8, S A Scott 3, A Scrol 8, M Smith 12, S C Stallings 6, T Veldhuizen 7, W Wolf 11, S Volpi 14, K Wiley 14, R Li 14, T Manolio 14, E Bottinger 3, M H Brilliant 10, D Carey 15, R L Chisholm 12, C G Chute 9, J L Haines 1, H Hakonarson 5, J B Harley 16, I A Holm 17, I J Kullo 7, G P Jarvik 2, E B Larson 8, C A McCarty 10, M S Williams 15, J C Denny 6, L J Rasmussen-Torvik 12, D M Roden 6, M D Ritchie 15 PMID: 26857349 PMCID: PMC5010878DOI: 10.1002/cpt.350
Pharmacogenet Genomics 2016 Apr;26(4):161-168. doi: 10.1097/FPC.0000000000000202.
PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation
Adam S Gordon 1, Robert S Fulton, Xiang Qin, Elaine R Mardis, Deborah A Nickerson, Steve ScherePMID: 26736087PMCID: PMC4935646DOI: 10.1097/FPC.0000000000000202